Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult

Mechanisms of Development

Volumn 117, Issue 1-2, 2002, Pages 363-367

  Denier, C ^a,b   Gasc, J M ^a   Chapon, F ^c   Domenga, V ^a   Lescoat, C ^a,b   Joutel, A ^a,b   Tournier Lasserve, E ^a,b  

^a INSERM   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cavernous angiomas; Cerebral cavernous malformations; In situ hybridisation; Krit1

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA; PROTEIN KRIT1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BRAIN; BRAIN MALFORMATION; BRAIN TISSUE; CEREBELLUM; CEREBRAL CAVERNOUS MALFORMATION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIFFERENTIATION; DIGESTIVE SYSTEM; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; ENDOMETRIUM; EPIDERMIS; EPITHELIUM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; RETINA; SPINAL CORD; SPINAL GANGLION; VASCULAR TISSUE;

ADULT; ANIMALS; CAPILLARIES; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; EPITHELIAL CELLS; EYE; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NERVOUS SYSTEM; NEURONS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 0036768349     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(02)00209-5     Document Type: Article

References (16)

1. Craig H.D., Gunel M., Cepeda O., Johnson E.W., Ptacek L., Steinberg G.K., Ogilvy C.S., Berg M.J., Crawford S.C., Scott R.M., Steichen-Gersdorf E., Sabroe R., Kennedy C.T., Mettler G., Beis M.J., Fryer A., Awad I.A., Lifton R.P. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum. Mol. Genet. 7:1998;1851-1858.
2. Dubovsky J., Zabramski J.M., Kurth J., Spetzler R.F., Rich S.S., Orr H.T., Weber J.L. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum. Mol. Genet. 4:1995;453-458.
3. Eerola I., Plate K.H., Spiegel R., Boon L.M., Mulliken J.B., Vikkula M. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum. Mol. Genet. 9:2000;1351-1355.
4. Faisst A.M., Gruss P. Bodenin: a novel murine gene expressed in restricted areas of the brain. Dev. Dyn. 212:1998;293-303.
5. Joutel A., Andreux F., Gaulis S., Domenga V., Cecillon M., Battail N., Piga N., Chapon F., Godfrain C., Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients J. Clin. Invest. 105:2000;597-605.
6. Labauge P., Laberge S., Brunereau L., Levy C., Maciazek J., Tournier-Lasserve E. Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de Neurochirurgie. Lancet. 352:1998;1892-1897.
7. Labauge P., Enjolras O., Bonerandi J.-J., Laberge S., Dandurand M., Joujoux J.-M., Tournier-Lasserve E. An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families. Ann. Neurol. 45:1999;250-254.
8. Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23:1999;189-193.
9. Otten P., Pizzolato G.P., Rilliet B., Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie. 35, 82-3:1989;128-131.
10. Russel D.S., Rubinstein L.J. Pathology of Tumors of the Nervous system. 5th ed. 1989;Williams and Wilkins, Baltimore, MD. pp. 730-736.
11. Sahoo T., Johnson E.W., Thomas J.W., Kuehl P.M., Jones T.L., Dokken C.G., Touchman J.W., Gallione C.J., Lee-Lin S.Q., Kosofsky B., Kurth J.H., Louis D.N., Mettler G., Morrison L., Gil-Nagel A., Rich S.S., Zabramski J.M., Boguski M.S., Green E.D., Marchuk D.A. Mutations in the gene encoding Krit1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8:1999;2325-2333.
12. Serebriiskii I., Estojak J., Sonoda G., Testa J.R., Golemis E.A. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene. 15:1997;1043-1049.
13. Sibony M., Segretain D., Gasc J.-M. Angiotensin-converting enzyme in murine testis: step-specific expression of the germinal isoform during spermiogenesis. Biol. Reprod. 50:1994;1015-1026.
14. Sibony M., Commo F., Callard P., Gasc J.-M. Enhancement of mRNA in situ hybridization signal by microwave heating. Lab. Invest. 73:1995;586-591.
15. Zawistowski J.S., Serebriiski I.G., Lee M.F., Golemis E.A., Marchuk D.A. Krit1 association with the integrin-binding protein icap1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum. Mol. Genet. 11:2002;389-396.
16. Zhang J., Clatterbuck R.E., Rigamonti D., Chang D.D., Dietz H.C. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum. Mol. Genet. 10:2001;2953-2960.